For more information on becoming an event/media partner, please contact Jon Liong at email@example.com.
Founded in 2014, PharmaDJ has expanded from a media outlet to a business intelligence platform including data-driven research, event organization and strategy consulting. Our areas of interest cover the entire drug life cycle, from early drug research, scientific translation to clinical development, commercial strategies, as well as market access strategies and public relations & communication strategies. Our editorial team are based in Shanghai, Guangzhou, Beijing, Suzhou, Nanjing and New Jersey.
BayHelix Group is a non-profit, invitation-only organization of business leaders of Chinese heritage that fosters the growth of the life sciences and healthcare industry around the Pacific Rim and beyond. Founded in 2001, BayHelix has grown to over 300 members throughout the U.S., Canada, and Greater China. The membership base covers virtually all of the world’s top pharmaceutical and biopharmaceutical companies, as well as leading services and investment firms. Over one third of the members are senior executives, over 80% have PhDs in the life sciences, and nearly half have MBAs from the leading business schools in U.S.
Biologics Innovation Group
To nurture an Eco-system for Biologics innovation and imprint China on Global map, BiG ( Biologics Innovation Group) was founded in the spring of 2014 by a group of KOLs of biologics and entrepreneurs. As a member-based NGO, BiG is driven of members, by members, and for members, running based the principle to keep the community “open and curious, respective and collaborative”. Now BiG has grown to a unique “phenomenon” contributing to biologics innovation eco-system, composing over 500 members from bio-pharmaceutical industry.
New Drug Founders Club
New Drug Founders Club was founded in March 27th, 2015, to form a network for founders of companies focusing on innovative new drug R&D and of companies providing relevant services. The club is highly prestigious in that only founders of such companies and people who well-recognized for having special and major contributions to new drug R&D in China (including China R&D heads of multinational companies, R&D heads of major domestic companies, partners of VC, and other nationally recognized leaders in new drug R&D) can be admitted to the club. This feature distinguishes this club from any other professional organizations in China or the world. Currently there are about 426 members in the club, with several new applications reviewed for approval every month.
In Collaboration With
Lingmed is a young, professional and fast growing company, it promotes world best in class intelligence databases to healthcare industry and provide with its premium services – Linkedbio - which provides analytical services and reports to help our clients to make better decisions and support BD sourcing activities.